Is hormone replacement therapy worth the risks?Subscription
The risks and benefits of hormone replacement therapy (HRT) have long been the source of confusion and controversy. Here we summarise the latest evidence to assist pharmacists in supporting patients thinking about HRT.
Changes outlined in the new pharmacy contract come into force on 1 October 2019, but pharmacists need clarity on these extra services and whether or not they will ultimately help or hinder patient care.
Having spent her entire career researching pharmacy services for drug users, Catriona Matheson is the ideal person to head up Scotland’s Drug Deaths Taskforce. Here, she explains what the group will do to tackle rising drug deaths in Scotland.
Hepatitis A infection: symptoms and managementSubscription
Pharmacists must understand how hepatitis A is spread and how it affects patients in order to ensure prompt, effective treatment and to reduce the spread of the infection.
Community pharmacists encounter patients at all stages in their life; however, patients who require palliative care require dedicated time and special consideration.
Case-based learning: recognising sepsisSubscription
Sepsis can lead to organ failure and death. However, early diagnosis and recognition in the pharmacy may help prevent these potentially fatal consequences.
A cross-sectional survey assessing adherence medication-assisted treatment for opioid use disorder, and the predictors of risk of poor adherence.
Callum Brown details a typical day improving the quality of care at a large NHS trust.
How to ensure your safety when working aloneSubscription
Pharmacy professionals give their thoughts and advice to a locum pharmacist required to work alone at night.
Since its introduction in 2017, the Oriel system has come a long way, but it must improve to ensure that preregistration training is suitable for all candidates.
An undercover investigation carried out by The Times is further proof that online pharmacies should be prohibited from prescribing and dispensing opioid medicines until they can prove they are safe.
Prescribing of 'low-risk' drugs to be expanded to wider range of healthcare professionals, government proposesSubscription
The government has said it will introduce legislation to allow a wider range of healthcare professionals in the NHS to prescribe “low-risk” medicines.
Barcode database errors could see wrong medicines dispensed to patients, warns pharmacy negotiatorSubscription
Pharmacists have been asked to “remain vigilant” when dispensing certain packs of medicines after a discrepancy was found between barcodes on the packs and corresponding data stored in an NHS Business Services Authority database.
Pharmacist consultation service risks putting 'massive pressure' on urgent care if too few pharmacies sign upSubscription
The Community Pharmacist Consultation Service needs at least 4,000 pharmacies to register by its go-live date of 29 October 2019 or referrals will “revert back” to general practice, a senior NHS England official has warned.
The Competition and Markets Authority has accepted an offer of £8m to be paid to the NHS by a drug manufacturer as part of an agreement following allegations of anticompetitive behaviour and the supply of a prescription drug.
Health boards in Wales may be required to conduct pharmaceutical needs assessments from 1 April 2020.
The government has issued the first serious shortage protocols to combat shortages of the antidepressant fluoxetine.